309 related articles for article (PubMed ID: 24444888)
1. Development of a feasible assay for the detection of GAA mutations in patients with Pompe disease.
Er TK; Chen CC; Chien YH; Liang WC; Kan TM; Jong YJ
Clin Chim Acta; 2014 Feb; 429():18-25. PubMed ID: 24444888
[TBL] [Abstract][Full Text] [Related]
2. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II.
McCready ME; Carson NL; Chakraborty P; Clarke JT; Callahan JW; Skomorowski MA; Chan AK; Bamforth F; Casey R; Rupar CA; Geraghty MT
Mol Genet Metab; 2007 Dec; 92(4):325-35. PubMed ID: 17723315
[TBL] [Abstract][Full Text] [Related]
3. p.D645E of acid α-glucosidase is the most common mutation in thai patients with infantile-onset pompe disease.
Amarinthnukrowh P; Tongkobpetch S; Kongpatanayothin A; Suphapeetiporn K; Shotelersuk V
Genet Test Mol Biomarkers; 2010 Dec; 14(6):835-7. PubMed ID: 21039225
[TBL] [Abstract][Full Text] [Related]
4. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular genetic study of infantile-onset Pompe disease in Chinese patients: identification of 6 novel mutations.
Fu L; Qiu W; Yu Y; Guo Y; Zhao P; Zhang X; Liu C; Li F; Huang H; Huang M; Chen S
Gene; 2014 Feb; 535(1):53-9. PubMed ID: 24269976
[TBL] [Abstract][Full Text] [Related]
6. Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.
Nilsson MI; Kroos MA; Reuser AJ; Hatcher E; Akhtar M; McCready ME; Tarnopolsky MA
Gene; 2014 Mar; 537(1):41-5. PubMed ID: 24384324
[TBL] [Abstract][Full Text] [Related]
7. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
[TBL] [Abstract][Full Text] [Related]
8. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program.
Labrousse P; Chien YH; Pomponio RJ; Keutzer J; Lee NC; Akmaev VR; Scholl T; Hwu WL
Mol Genet Metab; 2010 Apr; 99(4):379-83. PubMed ID: 20080426
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients.
Momosaki K; Kido J; Yoshida S; Sugawara K; Miyamoto T; Inoue T; Okumiya T; Matsumoto S; Endo F; Hirose S; Nakamura K
J Hum Genet; 2019 Aug; 64(8):741-755. PubMed ID: 31076647
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis and protein processing in late-onset Pompe disease patients with low levels of acid α-glucosidase activity.
Bali DS; Tolun AA; Goldstein JL; Dai J; Kishnani PS
Muscle Nerve; 2011 May; 43(5):665-70. PubMed ID: 21484825
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and acid alpha-glucosidase gene mutation in 7 Chinese patients with glycogen storage disease type II].
Liu Q; Zhao J; Wang ZX; Zhang W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(25):1981-5. PubMed ID: 24169249
[TBL] [Abstract][Full Text] [Related]
12. Detection of c. -32T>G (IVS1-13T>G) mutation of Pompe disease by real-time PCR in dried blood spot specimen.
Bobillo Lobato J; Sánchez Peral BA; Durán Parejo P; Jiménez Jiménez LM
Clin Chim Acta; 2013 Mar; 418():107-8. PubMed ID: 23305799
[TBL] [Abstract][Full Text] [Related]
13. p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?
Kroos MA; Mullaart RA; Van Vliet L; Pomponio RJ; Amartino H; Kolodny EH; Pastores GM; Wevers RA; Van der Ploeg AT; Halley DJ; Reuser AJ
Eur J Hum Genet; 2008 Aug; 16(8):875-9. PubMed ID: 18301443
[TBL] [Abstract][Full Text] [Related]
14. Three patients with glycogen storage disease type II and the mutational spectrum of GAA in Korean patients.
Park HD; Lee DH; Choi TY; Lee YK; Lee SY; Kim JW; Ki CS; Lee YW
Ann Clin Lab Sci; 2013; 43(3):311-6. PubMed ID: 23884227
[TBL] [Abstract][Full Text] [Related]
15. Two novel mutations in acid α-glucosidase gene in two patients with Pompe disease.
Aykut A; Onay H; Kose M; Erbas Canda E; Karaca E; Coker M; Ozkinay F
J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1265-7. PubMed ID: 25026126
[TBL] [Abstract][Full Text] [Related]
16. The genotype-phenotype correlation in Pompe disease.
Kroos M; Hoogeveen-Westerveld M; van der Ploeg A; Reuser AJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):59-68. PubMed ID: 22253258
[TBL] [Abstract][Full Text] [Related]
17. Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations.
Palmer RE; Amartino HM; Niizawa G; Blanco M; Pomponio RJ; Chamoles NA
Neuromuscul Disord; 2007 Jan; 17(1):16-22. PubMed ID: 17056254
[TBL] [Abstract][Full Text] [Related]
18. [Application of enzyme assay and gene analysis in the prenatal diagnosis for a family with glycogen storage disease type II].
Zeng MH; Qiu WJ; Gu XF; Wang Y; Zhou JD; Ye J; Han LS; Zhang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):261-5. PubMed ID: 21644219
[TBL] [Abstract][Full Text] [Related]
19. Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II.
Hermans MM; van Leenen D; Kroos MA; Beesley CE; Van Der Ploeg AT; Sakuraba H; Wevers R; Kleijer W; Michelakakis H; Kirk EP; Fletcher J; Bosshard N; Basel-Vanagaite L; Besley G; Reuser AJ
Hum Mutat; 2004 Jan; 23(1):47-56. PubMed ID: 14695532
[TBL] [Abstract][Full Text] [Related]
20. GAA gene mutation detection following clinical evaluation and enzyme activity analysis in Azeri Turkish patients with Pompe disease.
Gharesouran J; Jalaiei A; Hosseinzadeh A; Ghafouri-Fard S; Mokhtari Z; Ghahremanzadeh K; Rezazadeh N; Shiva S; Sadeghvand S; Taheri M; Rezazadeh M
Metab Brain Dis; 2020 Oct; 35(7):1127-1134. PubMed ID: 32504392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
